Alnylam Pharmaceuticals, Inc.ALNYNASDAQ
Loading
Gross Profit Growth TrendStable
Percentile Rank64
3Y CAGR+35.2%
5Y CAGR-12.6%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
+35.2%/yr
Annual compound
5Y CAGR
-12.6%/yr
Recent acceleration
Percentile
P64
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value |
|---|---|
| 2025 | 57.76% |
| 2024 | 26.81% |
| 2023 | 74.75% |
| 2022 | 23.36% |
| 2021 | 69.75% |
| 2020 | 113.06% |
| 2019 | 166.31% |
| 2018 | -4.49% |
| 2017 | 62.31% |
| 2016 | 14.75% |